At AGBT, Pacific Biosciences Unveils Commercial Instrument; Shows 10 kb Read, Variety of Applications
March 02, 2010
At AGBT, Pacific Biosciences Unveils Commercial Instrument; Shows 10 kb Read, Variety of Applications
Pacific Biosciences presented its commercial sequencing instrument, the Pacbio RS, publicly for the first time last week, along with a 10-kilobase read generated on the machine and a number of applications, ranging from influenza virus sequencing to structural variation analysis in humans and mutation detection in cancer.
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- Expression Analysis Starts Providing Sequencing Services on PacBio RS
June 7, 2011 / In Sequence - Pacific Biosciences Adds 13 Partners for Ancillary Products, Services
February 8, 2011 / In Sequence - In Sequence Annual Survey: Illumina Leads Market but Most Users Believe PacBio Will Provide Next Big Leap
January 25, 2011 / In Sequence - New Sequencing Platforms Drive Choice, Competition, Lawsuits in 2010
January 4, 2011 / In Sequence - PacBio, Collaborators Sequence Haitian Cholera Strain to Pinpoint Origin; Sequencing Completed in Two Days
December 14, 2010 / In Sequence